Mortality rates of hip fracture patients with non-operative treatment

Joonha Lee, Keun-Young Shin1, Hyun-Wook Nam

  • 1Department of Orthopedic Surgery, Bundang Jesaeng General Hospital, Seongnam, South Korea. korsky21@hanmail.net.

Insights

Non-operative hip fracture treatment leads to high patient mortality, with respiratory and cardiovascular diseases being primary causes of death. Further research is needed to improve survival rates and quality of life for these patients.

Area of Science:

  • Geriatric Medicine
  • Orthopedic Surgery
  • Public Health

Background:

  • Hip fractures are a common and serious injury in the elderly.
  • Non-operative management is sometimes chosen for hip fractures, particularly in frail patients.
  • High mortality rates are associated with hip fractures, necessitating investigation into contributing factors.

Purpose of the Study:

  • To analyze patient mortality rates following non-operative hip fracture treatment.
  • To determine the distribution of causes of death in this patient cohort.
  • To identify factors influencing mortality in patients treated non-operatively for hip fractures.

Main Methods:

  • Retrospective analysis of 93 patients (mean age 86.0 years) treated non-operatively for hip fractures between 2013 and 2019.
  • Collection and analysis of survival data, dates, and causes of death.
  • Comparison of baseline demographics, functional status (ambulation, mobility scores), and comorbidities (ASA PS) with one-year mortality.

Main Results:

  • High mortality rates observed: 40.9% at 3 months, 74.4% at 12 months, and 87.5% at 24 months.
  • Respiratory diseases (33.3%) and cardiovascular diseases (13.6%) were the leading causes of death.
  • No significant association found between baseline characteristics (age, sex, fracture site, functional status, ASA PS) and one-year mortality.

Conclusions:

  • Non-operative treatment of hip fractures is associated with a substantial and high mortality rate.
  • Respiratory and cardiovascular conditions are the primary drivers of mortality in this population.
  • Further research and interventions are crucial to mitigate mortality and enhance the quality of life for patients with non-operatively treated hip fractures.
Abstract